Evidence map›Paper›PMID 38981916›Full record

ArticleJournal of cancer research and clinical oncology2024

Developing a deep learning model for predicting ovarian cancer in Ovarian-Adnexal Reporting and Data System Ultrasound (O-RADS US) Category 4 lesions: A multicenter study.

Wenting Xie, Wenjie Lin, Ping Li, Hongwei Lai, Zhilan Wang, Peizhong Liu, Yijun Huang, Yao Liu, Lina Tang, Guorong Lyu

Abstract readMulticenter Study
In one paragraph

Article in Journal of cancer research and clinical oncology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Wenting Xie *Department of Ultrasound Medicine, The Second Affiliated Hospital of Fujian medical University, Quanzhou, Fujian Province, 362000, China.
Wenjie Lin *Department of Ultrasound Medicine, The Second Affiliated Hospital of Fujian medical University, Quanzhou, Fujian Province, 362000, China.
Ping LiDepartment of Gynecology and Obstetrics, Quanzhou First Hospital Affiliated to Fujian Medical University, Quanzhou, Fujian, 362000, China.
Hongwei LaiDepartment of Ultrasound, Fujian Provincial Maternity and Children's Hospital, Fuzhou, Fujian Province, 350014, China.
Zhilan WangDepartment of Ultrasound, Nanping First Hospital Affiliated to Fujian Medical University, Nanping, Fujian Province, 35300, China.
Peizhong LiuSchool of Medicine, Huaqiao University, Quanzhou, Fujian Province, 362000, China.
Yijun HuangDepartment of Ultrasound, Fujian Cancer Hospital, Clinical Oncology School of Fujian Medical University, Fuzhou, Fujian Province, 350014, China.
Yao LiuQuanzhou Bolang Technology Group Co., Ltd, Quanzhou, Fujian Province, 362000, China. yowk0529@gmail.com.
Lina TangDepartment of Ultrasound, Fujian Cancer Hospital, Clinical Oncology School of Fujian Medical University, Fuzhou, Fujian Province, 350014, China. tanglina@fjzlhospital.com.
Guorong LyuDepartment of Ultrasound Medicine, The Second Affiliated Hospital of Fujian medical University, Quanzhou, Fujian Province, 362000, China. lgr_feus@sina.com.

Funding

Fujian Provincial Health Technology Project 2022QNA044Joint Funds for the innovation of science and Technology,Fujian province 2023Y9397the Startup Fund for Scientific Research, Fujian Medical University 2019QH1194
6 · The paper itself

Abstract

purposeTo develop a deep learning (DL) model for differentiating between benign and malignant ovarian tumors of Ovarian-Adnexal Reporting and Data System Ultrasound (O-RADS US) Category 4 lesions, and validate its diagnostic performance.

methodsA retrospective analysis of 1619 US images obtained from three centers from December 2014 to March 2023. DeepLabV3 and YOLOv8 were jointly used to segment, classify, and detect ovarian tumors. Precision and recall and area under the receiver operating characteristic curve (AUC) were employed to assess the model performance.

resultsA total of 519 patients (including 269 benign and 250 malignant masses) were enrolled in the study. The number of women included in the training, validation, and test cohorts was 426, 46, and 47, respectively. The detection models exhibited an average precision of 98.68% (95% CI: 0.95-0.99) for benign masses and 96.23% (95% CI: 0.92-0.98) for malignant masses. Moreover, in the training set, the AUC was 0.96 (95% CI: 0.94-0.97), whereas in the validation set, the AUC was 0.93(95% CI: 0.89-0.94) and 0.95 (95% CI: 0.91-0.96) in the test set. The sensitivity, specificity, accuracy, positive predictive value, and negative predictive values for the training set were 0.943,0.957,0.951,0.966, and 0.936, respectively, whereas those for the validation set were 0.905,0.935, 0.935,0.919, and 0.931, respectively. In addition, the sensitivity, specificity, accuracy, positive predictive value, and negative predictive value for the test set were 0.925, 0.955, 0.941, 0.956, and 0.927, respectively.

conclusionThe constructed DL model exhibited high diagnostic performance in distinguishing benign and malignant ovarian tumors in O-RADS US category 4 lesions.

Indexed as

Deep LearningOvarian NeoplasmsUltrasonographyAdultAgedFemaleHumansMiddle AgedRetrospective StudiesYoung AdultDeep learningOvarian-adnexal reporting and data systemOvarian cancerUltrasonography

Identifiers

PMID38981916
PMCPMC11233367

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.